The continuous glucose monitoring devices market size has grown rapidly in recent years. It will grow from $9.79 billion in 2025 to $11.45 billion in 2026 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to increasing diabetes prevalence across age groups, expansion of home-based glucose monitoring, improved sensor miniaturization, growing patient preference for continuous monitoring, rising adoption of digital health solutions.
The continuous glucose monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $21.13 billion in 2030 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing demand for interoperable diabetes devices, rising investments in ai-driven glucose prediction, expansion of remote diabetes care models, growing focus on data-driven treatment optimization, increasing adoption of next-generation sensor materials. Major trends in the forecast period include increasing adoption of non-invasive cgm technologies, rising demand for cloud-connected glucose monitoring, growing integration of predictive glucose analytics, expansion of long-wear sensor solutions, enhanced focus on user-friendly device design.
The growing prevalence of diabetes is expected to drive the expansion of the continuous glucose monitoring devices market. Diabetes is a condition where the body cannot properly regulate blood sugar levels, either due to insufficient insulin production or insulin resistance. The increasing rates of diabetes are primarily attributed to factors such as poor diets, sedentary lifestyles, obesity, aging populations, and genetic predispositions. Continuous glucose monitoring (CGM) devices aid in managing diabetes by providing real-time data on blood glucose levels, enabling timely treatment adjustments and lifestyle changes. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the percentage of patients achieving target HbA1c levels reached 37.9%, the highest ever recorded in the National Diabetes Audit (NDA). As a result, the rising prevalence of diabetes is significantly contributing to the growth of the continuous glucose monitoring devices market.
Leading companies in the continuous glucose monitoring devices market are focused on developing innovative technologies, such as over-the-counter continuous glucose monitors, to improve accessibility, accuracy, and usability for individuals managing blood glucose levels. An over-the-counter CGM device allows users to continuously monitor their blood glucose levels without the need for a prescription. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched the Lingo continuous glucose monitoring system. This device provides users with real-time glucose data, offering continuous monitoring and instant feedback on blood sugar levels throughout the day. It features a sleek design with easy-to-read displays and integrates with mobile apps for tracking trends and receiving alerts.
In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition allows Abbott to enhance its diabetes care offerings by combining Bigfoot Biomedical's smart insulin management systems with its Freestyle Libre technology. Bigfoot Biomedical, a US-based medical technology company, specializes in solutions that integrate with continuous glucose monitoring (CGM) devices.
Major companies operating in the continuous glucose monitoring devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton Dickinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., Nemaura Medical Inc.
North America was the largest region in the continuous glucose monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous glucose monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the continuous glucose monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the continuous glucose monitoring devices market by increasing costs of imported sensors, transmitters, microchips, wireless communication modules, and cloud-enabled hardware components. Hospitals and homecare settings in North America and Europe are most affected due to high reliance on imported electronics, while Asia-Pacific faces cost escalation in manufacturing and exports. These tariffs are increasing device prices and slowing upgrade cycles. However, they are also driving domestic production, localized electronics sourcing, and innovation in cost-efficient CGM device architectures.
The continuous glucose monitoring devices market research report is one of a series of new reports that provides continuous glucose monitoring devices market statistics, including continuous glucose monitoring devices industry global market size, regional shares, competitors with a continuous glucose monitoring devices market share, detailed continuous glucose monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the continuous glucose monitoring devices industry. This continuous glucose monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Continuous glucose monitoring (CGM) devices are used to track blood sugar levels in real time by placing a sensor under the skin. These devices offer continuous data, trend insights, and alerts for both high and low blood sugar levels, which helps manage diabetes more effectively. CGM devices reduce the need for frequent finger pricks and improve glucose control.
The primary components of continuous glucose monitoring devices include transmitters, sensors, and receivers. Transmitters are the components that transmit glucose level data from the sensor to the receiver or connected device for monitoring. They typically connect via Bluetooth or 4G technology. CGM devices are used across various demographics, including both children and adults, for managing conditions such as gestational diabetes, type-1 diabetes, and type-2 diabetes. These devices are utilized in a range of settings, including hospitals, homecare environments, and other healthcare settings.
The continuous glucose monitoring (CGM) devices include revenues earned by entities by providing services such as real-time glucose monitoring, data sharing, trend analysis, and high or low alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring (CGM) devices market also consists of sales of products including dexcom, freestyle libre, medtronic, and eversense. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The continuous glucose monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $21.13 billion in 2030 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing demand for interoperable diabetes devices, rising investments in ai-driven glucose prediction, expansion of remote diabetes care models, growing focus on data-driven treatment optimization, increasing adoption of next-generation sensor materials. Major trends in the forecast period include increasing adoption of non-invasive cgm technologies, rising demand for cloud-connected glucose monitoring, growing integration of predictive glucose analytics, expansion of long-wear sensor solutions, enhanced focus on user-friendly device design.
The growing prevalence of diabetes is expected to drive the expansion of the continuous glucose monitoring devices market. Diabetes is a condition where the body cannot properly regulate blood sugar levels, either due to insufficient insulin production or insulin resistance. The increasing rates of diabetes are primarily attributed to factors such as poor diets, sedentary lifestyles, obesity, aging populations, and genetic predispositions. Continuous glucose monitoring (CGM) devices aid in managing diabetes by providing real-time data on blood glucose levels, enabling timely treatment adjustments and lifestyle changes. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the percentage of patients achieving target HbA1c levels reached 37.9%, the highest ever recorded in the National Diabetes Audit (NDA). As a result, the rising prevalence of diabetes is significantly contributing to the growth of the continuous glucose monitoring devices market.
Leading companies in the continuous glucose monitoring devices market are focused on developing innovative technologies, such as over-the-counter continuous glucose monitors, to improve accessibility, accuracy, and usability for individuals managing blood glucose levels. An over-the-counter CGM device allows users to continuously monitor their blood glucose levels without the need for a prescription. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched the Lingo continuous glucose monitoring system. This device provides users with real-time glucose data, offering continuous monitoring and instant feedback on blood sugar levels throughout the day. It features a sleek design with easy-to-read displays and integrates with mobile apps for tracking trends and receiving alerts.
In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition allows Abbott to enhance its diabetes care offerings by combining Bigfoot Biomedical's smart insulin management systems with its Freestyle Libre technology. Bigfoot Biomedical, a US-based medical technology company, specializes in solutions that integrate with continuous glucose monitoring (CGM) devices.
Major companies operating in the continuous glucose monitoring devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton Dickinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., Nemaura Medical Inc.
North America was the largest region in the continuous glucose monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous glucose monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the continuous glucose monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the continuous glucose monitoring devices market by increasing costs of imported sensors, transmitters, microchips, wireless communication modules, and cloud-enabled hardware components. Hospitals and homecare settings in North America and Europe are most affected due to high reliance on imported electronics, while Asia-Pacific faces cost escalation in manufacturing and exports. These tariffs are increasing device prices and slowing upgrade cycles. However, they are also driving domestic production, localized electronics sourcing, and innovation in cost-efficient CGM device architectures.
The continuous glucose monitoring devices market research report is one of a series of new reports that provides continuous glucose monitoring devices market statistics, including continuous glucose monitoring devices industry global market size, regional shares, competitors with a continuous glucose monitoring devices market share, detailed continuous glucose monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the continuous glucose monitoring devices industry. This continuous glucose monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Continuous glucose monitoring (CGM) devices are used to track blood sugar levels in real time by placing a sensor under the skin. These devices offer continuous data, trend insights, and alerts for both high and low blood sugar levels, which helps manage diabetes more effectively. CGM devices reduce the need for frequent finger pricks and improve glucose control.
The primary components of continuous glucose monitoring devices include transmitters, sensors, and receivers. Transmitters are the components that transmit glucose level data from the sensor to the receiver or connected device for monitoring. They typically connect via Bluetooth or 4G technology. CGM devices are used across various demographics, including both children and adults, for managing conditions such as gestational diabetes, type-1 diabetes, and type-2 diabetes. These devices are utilized in a range of settings, including hospitals, homecare environments, and other healthcare settings.
The continuous glucose monitoring (CGM) devices include revenues earned by entities by providing services such as real-time glucose monitoring, data sharing, trend analysis, and high or low alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring (CGM) devices market also consists of sales of products including dexcom, freestyle libre, medtronic, and eversense. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Continuous Glucose Monitoring Devices Market Characteristics
3. Continuous Glucose Monitoring Devices Market Supply Chain Analysis
4. Global Continuous Glucose Monitoring Devices Market Trends and Strategies
5. Continuous Glucose Monitoring Devices Market Analysis of End Use Industries
7. Global Continuous Glucose Monitoring Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Continuous Glucose Monitoring Devices Total Addressable Market (TAM) Analysis for the Market
9. Continuous Glucose Monitoring Devices Market Segmentation
10. Continuous Glucose Monitoring Devices Market Regional and Country Analysis
11. Asia-Pacific Continuous Glucose Monitoring Devices Market
12. China Continuous Glucose Monitoring Devices Market
13. India Continuous Glucose Monitoring Devices Market
14. Japan Continuous Glucose Monitoring Devices Market
15. Australia Continuous Glucose Monitoring Devices Market
16. Indonesia Continuous Glucose Monitoring Devices Market
17. South Korea Continuous Glucose Monitoring Devices Market
18. Taiwan Continuous Glucose Monitoring Devices Market
19. South East Asia Continuous Glucose Monitoring Devices Market
20. Western Europe Continuous Glucose Monitoring Devices Market
21. UK Continuous Glucose Monitoring Devices Market
22. Germany Continuous Glucose Monitoring Devices Market
23. France Continuous Glucose Monitoring Devices Market
24. Italy Continuous Glucose Monitoring Devices Market
25. Spain Continuous Glucose Monitoring Devices Market
26. Eastern Europe Continuous Glucose Monitoring Devices Market
27. Russia Continuous Glucose Monitoring Devices Market
28. North America Continuous Glucose Monitoring Devices Market
29. USA Continuous Glucose Monitoring Devices Market
30. Canada Continuous Glucose Monitoring Devices Market
31. South America Continuous Glucose Monitoring Devices Market
32. Brazil Continuous Glucose Monitoring Devices Market
33. Middle East Continuous Glucose Monitoring Devices Market
34. Africa Continuous Glucose Monitoring Devices Market
36. Continuous Glucose Monitoring Devices Market Competitive Landscape and Company Profiles
37. Continuous Glucose Monitoring Devices Market Other Major and Innovative Companies
40. Continuous Glucose Monitoring Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Continuous Glucose Monitoring Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses continuous glucose monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for continuous glucose monitoring devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous glucose monitoring devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Transmitters; Sensors; Receivers2) By Connectivity: Bluetooth; 4G
3) By Demography: Child Population; Adult Population
4) By Application: Gestational Diabetes; Type-2 Diabetes; Type-1 Diabetes
5) By End-Use: Hospitals; Homecare Settings; Other End Users
Subsegments:
1) By Transmitters: Bluetooth-Enabled Transmitters; Wireless Transmitters; Integrated Transmitter-Receiver Systems2) By Sensors: Enzyme-Based Sensors; Electrochemical Sensors; Non-Invasive Sensors
3) By Receivers: Mobile Device Integration (Smartphone Receivers); Standalone Receivers; Cloud-Based Data Sync Receivers
Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche AG; Sanofi S.A.; Abbott Laboratories; Medtronic Public Limited Company; Novo Nordisk A/S; Becton Dickinson and Company; A. Menarini Diagnostics S.r.l.; Dexcom Inc.; Bionime Corporation; Insulet Corporation; Ascensia Diabetes Care Holdings AG; Tandem Diabetes Care Inc.; i-Sens Inc.; Senseonics Holdings Inc.; Medtrum Technologies Inc.; Biolinq Inc.; GlySens Incorporated; Glucotrack Inc.; Nemaura Medical Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Continuous Glucose Monitoring Devices market report include:- Johnson & Johnson
- F. Hoffmann-La Roche AG
- Sanofi S.A.
- Abbott Laboratories
- Medtronic Public Limited Company
- Novo Nordisk A/S
- Becton Dickinson and Company
- A. Menarini Diagnostics S.r.l.
- Dexcom Inc.
- Bionime Corporation
- Insulet Corporation
- Ascensia Diabetes Care Holdings AG
- Tandem Diabetes Care Inc.
- i-Sens Inc.
- Senseonics Holdings Inc.
- Medtrum Technologies Inc.
- Biolinq Inc.
- GlySens Incorporated
- Glucotrack Inc.
- Nemaura Medical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 11.45 Billion |
| Forecasted Market Value ( USD | $ 21.13 Billion |
| Compound Annual Growth Rate | 16.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
